CymaBay Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.991; its P/E ratio is -32.75; CymaBay Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 57.00K	-	$ 31.02M	-	-
Gross Profit	$ 57.00K	-	$ 31.02M	-	-
EBIT	$ -36.82M	$ -29.04M	$ 3.81M	$ -24.38M	$ -23.48M
EBITDA	$ -39.23M	$ -30.92M	$ 2.03M	$ -25.49M	$ -23.89M
Net Income Common Stockholders	$ -41.90M	$ -33.88M	$ -808.00K	$ -28.78M	$ -26.63M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 394.25M	$ 438.78M	$ 213.84M	$ 236.37M	$ 135.49M
Total Assets	$ 434.69M	$ 451.05M	$ 226.65M	$ 244.59M	$ 141.85M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 30.00K
Net Debt	$ -394.25M	$ -438.78M	$ -213.84M	$ -236.37M	$ -135.46M
Total Liabilities	$ 142.43M	$ 124.86M	$ 118.24M	$ 141.13M	$ 105.70M
Stockholders Equity	$ 292.26M	$ 326.19M	$ 108.45M	$ 104.22M	$ 36.15M
Cash Flow	-
Free Cash Flow	$ -27.56M	$ -26.14M	$ -25.51M	$ 6.24M	$ -18.77M
Operating Cash Flow	$ -27.38M	$ -26.14M	$ -25.44M	$ 6.43M	$ -18.76M
Investing Cash Flow	$ -42.11M	$ 15.46M	$ 719.00K	$ -60.64M	$ 8.36M
Financing Cash Flow	$ 2.73M	$ 248.92M	$ 1.05M	$ 93.07M	-

Currency in USD

CymaBay Therapeutics Earnings and Revenue History

Income Statement >

CymaBay Therapeutics Debt to Assets

Balance Sheet >

CymaBay Therapeutics Cash Flow

Cash Flow >

CymaBay Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing